SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022956
Filing Date
2022-08-15
Accepted
2022-08-15 17:06:45
Documents
37
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 337493
2 ex31-1.htm EX-31.1 17458
3 ex32-1.htm EX-32.1 6530
  Complete submission text file 0001493152-22-022956.txt   1725900

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glsi-20220630.xsd EX-101.SCH 14031
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glsi-20220630_cal.xml EX-101.CAL 22276
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glsi-20220630_def.xml EX-101.DEF 53405
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glsi-20220630_lab.xml EX-101.LAB 135576
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glsi-20220630_pre.xml EX-101.PRE 107724
31 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 152234
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 221166586
SIC: 2834 Pharmaceutical Preparations